Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease

Simona Eleuteri, Saviana Di Giovanni, Edward Rockenstein, Mike Mante, Antony Adame, Margarita Trejo, Wolf Wrasidlo, Fang Wu, Patrick C. Fraering, Eliezer Masliah, Hilal A. Lashuel

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aβ accumulation plays a central role in the pathogenesis of Alzheimer's disease (AD). Recent studies suggest that the process of Aβ nucleated polymerization is essential for Aβ fibril formation, pathology spreading and toxicity. Therefore, targeting this process represents an effective therapeutic strategy to slow or block disease progression. To discover compounds that might interfere with the Aβ seeding capacity, toxicity and pathology spreading, we screened a focused library of FDA-approved drugs in vitro using a seeding polymerization assay and identified small molecule inhibitors that specifically interfered with Aβ seeding-mediated fibril growth and toxicity. Mitoxantrone, bithionol and hexachlorophene were found to be the strongest inhibitors of fibril growth and protected primary cortical neuronal cultures against Aβ-induced toxicity. Next, we assessed the effects of these three inhibitors in vivo in the mThy1-APPtg mouse model of AD (8-month-old mice). We found that mitoxantrone and bithionol, but not hexachlorophene, stabilized diffuse amyloid plaques, reduced the levels of Aβ42 oligomers and ameliorated synapse loss, neuronal damage and astrogliosis. Together, our findings suggest that targeting fibril growth and Aβ seeding capacity constitutes a viable and effective strategy for protecting against neurodegeneration and disease progression in AD.

Original languageEnglish
Pages (from-to)235-251
Number of pages17
JournalNeurobiology of Disease
Volume74
DOIs
Publication statusPublished - 1 Feb 2015
Externally publishedYes

Fingerprint

Bithionol
Hexachlorophene
Mitoxantrone
Polymerization
Disease Progression
Alzheimer Disease
Pathology
Growth Inhibitors
Amyloid Plaques
Growth
Synapses
Therapeutics
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • Amyloid protein
  • Aβ seeding-mediated aggregation
  • Aβ-propagation
  • Drug discovery
  • Inhibitors

ASJC Scopus subject areas

  • Neurology

Cite this

Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease. / Eleuteri, Simona; Di Giovanni, Saviana; Rockenstein, Edward; Mante, Mike; Adame, Antony; Trejo, Margarita; Wrasidlo, Wolf; Wu, Fang; Fraering, Patrick C.; Masliah, Eliezer; Lashuel, Hilal A.

In: Neurobiology of Disease, Vol. 74, 01.02.2015, p. 235-251.

Research output: Contribution to journalArticle

Eleuteri, S, Di Giovanni, S, Rockenstein, E, Mante, M, Adame, A, Trejo, M, Wrasidlo, W, Wu, F, Fraering, PC, Masliah, E & Lashuel, HA 2015, 'Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease', Neurobiology of Disease, vol. 74, pp. 235-251. https://doi.org/10.1016/j.nbd.2014.08.017
Eleuteri, Simona ; Di Giovanni, Saviana ; Rockenstein, Edward ; Mante, Mike ; Adame, Antony ; Trejo, Margarita ; Wrasidlo, Wolf ; Wu, Fang ; Fraering, Patrick C. ; Masliah, Eliezer ; Lashuel, Hilal A. / Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease. In: Neurobiology of Disease. 2015 ; Vol. 74. pp. 235-251.
@article{321f78a99ce243e1acb3fd5ef418c712,
title = "Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease",
abstract = "Aβ accumulation plays a central role in the pathogenesis of Alzheimer's disease (AD). Recent studies suggest that the process of Aβ nucleated polymerization is essential for Aβ fibril formation, pathology spreading and toxicity. Therefore, targeting this process represents an effective therapeutic strategy to slow or block disease progression. To discover compounds that might interfere with the Aβ seeding capacity, toxicity and pathology spreading, we screened a focused library of FDA-approved drugs in vitro using a seeding polymerization assay and identified small molecule inhibitors that specifically interfered with Aβ seeding-mediated fibril growth and toxicity. Mitoxantrone, bithionol and hexachlorophene were found to be the strongest inhibitors of fibril growth and protected primary cortical neuronal cultures against Aβ-induced toxicity. Next, we assessed the effects of these three inhibitors in vivo in the mThy1-APPtg mouse model of AD (8-month-old mice). We found that mitoxantrone and bithionol, but not hexachlorophene, stabilized diffuse amyloid plaques, reduced the levels of Aβ42 oligomers and ameliorated synapse loss, neuronal damage and astrogliosis. Together, our findings suggest that targeting fibril growth and Aβ seeding capacity constitutes a viable and effective strategy for protecting against neurodegeneration and disease progression in AD.",
keywords = "Alzheimer's disease, Amyloid protein, Aβ seeding-mediated aggregation, Aβ-propagation, Drug discovery, Inhibitors",
author = "Simona Eleuteri and {Di Giovanni}, Saviana and Edward Rockenstein and Mike Mante and Antony Adame and Margarita Trejo and Wolf Wrasidlo and Fang Wu and Fraering, {Patrick C.} and Eliezer Masliah and Lashuel, {Hilal A.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.nbd.2014.08.017",
language = "English",
volume = "74",
pages = "235--251",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease

AU - Eleuteri, Simona

AU - Di Giovanni, Saviana

AU - Rockenstein, Edward

AU - Mante, Mike

AU - Adame, Antony

AU - Trejo, Margarita

AU - Wrasidlo, Wolf

AU - Wu, Fang

AU - Fraering, Patrick C.

AU - Masliah, Eliezer

AU - Lashuel, Hilal A.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Aβ accumulation plays a central role in the pathogenesis of Alzheimer's disease (AD). Recent studies suggest that the process of Aβ nucleated polymerization is essential for Aβ fibril formation, pathology spreading and toxicity. Therefore, targeting this process represents an effective therapeutic strategy to slow or block disease progression. To discover compounds that might interfere with the Aβ seeding capacity, toxicity and pathology spreading, we screened a focused library of FDA-approved drugs in vitro using a seeding polymerization assay and identified small molecule inhibitors that specifically interfered with Aβ seeding-mediated fibril growth and toxicity. Mitoxantrone, bithionol and hexachlorophene were found to be the strongest inhibitors of fibril growth and protected primary cortical neuronal cultures against Aβ-induced toxicity. Next, we assessed the effects of these three inhibitors in vivo in the mThy1-APPtg mouse model of AD (8-month-old mice). We found that mitoxantrone and bithionol, but not hexachlorophene, stabilized diffuse amyloid plaques, reduced the levels of Aβ42 oligomers and ameliorated synapse loss, neuronal damage and astrogliosis. Together, our findings suggest that targeting fibril growth and Aβ seeding capacity constitutes a viable and effective strategy for protecting against neurodegeneration and disease progression in AD.

AB - Aβ accumulation plays a central role in the pathogenesis of Alzheimer's disease (AD). Recent studies suggest that the process of Aβ nucleated polymerization is essential for Aβ fibril formation, pathology spreading and toxicity. Therefore, targeting this process represents an effective therapeutic strategy to slow or block disease progression. To discover compounds that might interfere with the Aβ seeding capacity, toxicity and pathology spreading, we screened a focused library of FDA-approved drugs in vitro using a seeding polymerization assay and identified small molecule inhibitors that specifically interfered with Aβ seeding-mediated fibril growth and toxicity. Mitoxantrone, bithionol and hexachlorophene were found to be the strongest inhibitors of fibril growth and protected primary cortical neuronal cultures against Aβ-induced toxicity. Next, we assessed the effects of these three inhibitors in vivo in the mThy1-APPtg mouse model of AD (8-month-old mice). We found that mitoxantrone and bithionol, but not hexachlorophene, stabilized diffuse amyloid plaques, reduced the levels of Aβ42 oligomers and ameliorated synapse loss, neuronal damage and astrogliosis. Together, our findings suggest that targeting fibril growth and Aβ seeding capacity constitutes a viable and effective strategy for protecting against neurodegeneration and disease progression in AD.

KW - Alzheimer's disease

KW - Amyloid protein

KW - Aβ seeding-mediated aggregation

KW - Aβ-propagation

KW - Drug discovery

KW - Inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84920732059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920732059&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2014.08.017

DO - 10.1016/j.nbd.2014.08.017

M3 - Article

VL - 74

SP - 235

EP - 251

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -